What is it about?

this article explains the history behind the development of neprilysin inhibitors as a new treatment for heart failure - with final success with sacubitril/valsartan

Featured Image

Why is it important?

neprilysin inhibition has been the most recent breakthrough in the treatment of heart failure and the first new treatment (sacubitril/valsartan) in 15 years to reduce mortality in this condition

Read the Original

This page is a summary of: Neprilysin inhibition to treat heart failure: a tale of science, serendipity, and second chances, European Journal of Heart Failure, March 2015, Wiley,
DOI: 10.1002/ejhf.250.
You can read the full text:

Read

Contributors

The following have contributed to this page